RIZE Pneumococcal Vaccination Best Practices Learning Collaborative
OverviewAMGA Foundation, with support from Pfizer, launched a 12-month initiative focused on helping medical groups develop and implement strategies to vaccinate high-risk adults 19-64 with underlying medical conditions based on the 2022 ACIP pneumococcal vaccine guidelienes in primary care and specialty clinical settings.
The RIZE Pneumococcal Vaccination Best Practices Learning Collaborative (Pneumococcal Vaccination Collaborative) is designed to provide a platform for participating organizations to improve both clinical and economic outcomes for this patient population through the development and implementation of quality improvement projects, best pratice sharing, and peer learning.
AMGA Member Participants
Eight healthcare organizations are participating in the Pneumococcal Vaccination Collaborative:
- Houston Methodist Physician Organization
- Kelsey-Seybold Clinic
- McFarland Clinic, PC
- Norton Medical Group
- Olmsted Medical Center
- Palo Alto Medical Foundation
- Sharp-Rees Stealy Medical Group, Inc.
- St. Elizabeth Physicians
AdvisorsThe Advisory Committee for the Pneumococcal Vaccination Collaborative consists of the following individuals:
Carolyn Bridges, MD, FACP
Director of Adult Immunizations, Immunize.org
Meredreth Maynard, BSN, RN, MBA
Director of Quality Improvement, AHS Oklahoma Physician Group, LLC dba Utica Park Clinic
Stephen Combs, MD, CPE, CPHQ, FACFE, FAAP
Vice-President and Chief Medical Officer, Ballad Health Medical Associates, Ballad Health
Erica Chilson, PharmD
Senior Director of US Medical Affairs, Pfizer Inc.